Skip to main content
. 2023 Sep 30;129(11):1747–1758. doi: 10.1038/s41416-023-02451-3

Table 3.

Association of stromal tumour infiltrating lymphocytes-stromal cells co-occurrence and intratumoural tumour infiltrating lymphocytes-tumour cells co-occurrence with clinicopathological parameters in the study cohorts.

Stromal tumour infiltrating lymphocytes (sTILs)-stromal cells co-occurrence Intratumoural tumour infiltrating lymphocytes (tTILs)-tumour cells co-occurrence
Discovery set Test set External validation cohort Discovery set Test set External validation cohort
Characteristics Mean Rank p-value Mean Rank p-value Mean Rank p-value Mean Rank p-value Mean Rank p-value Mean Rank p-value
Age at diagnosis (years)
 < 50 943  < 0.001 371 0.01 171 0.4 886  < 0.001 371 0.01 160 0.9
≥ 50 749 322 158 751 322 159
Menopausal status
Premenopausal 906  < 0.001 380  < 0.001 NA NA 849  < 0.001 364 0.01 NA NA
Postmenopausal 749 317 755 322
Tumour size (cm)
 < 2 721 <0.001 298 <0.001 147 0.004 714 <0.001 304 <0.001 141  < 0.001
≥ 2 962 402 177 950 388 186
Tumour grade
1 611  < 0.001 265  < 0.001 128 <0.001 569  < 0.001 262  < 0.001 123 <0.001
2 766 328 170 760 327 173
3 1045 418 212 1062 424 214
Mitotic count
1 713  < 0.001 300  < 0.001 149 <0.001 694  < 0.001 298  < 0.001 145 <0.001
2 926 401 196 906 393 216
3 1070 420 202 1129 448 208
Nuclear pleomorphism
1 365  < 0.001 255  < 0.001 188 <0.001 545  < 0.001 158  < 0.001 157 <0.001
2 659 281 141 666 299 144
3 927 390 192 897 372 187
Tubule formation
1 590  < 0.001 261 0.004 138 0.07 520  < 0.001 245  < 0.001 131 0.006
2 794 327 156 732 324 153
3 814 344 171 842 349 176
Nottingham Prognostic Index
Good prognostic group 672  < 0.001 284  < 0.001 141 <0.001 665  < 0.001 289  < 0.001 138 <0.001
Moderate prognostic group 930 385 194 916 381 198
Poor prognostic group 1173 450 193 1206 378 271
Histological types
No special type (NST) 862  < 0.001 350  < 0.001 166 0.002 873  < 0.001 362  < 0.001 169 0.005
Lobular 666 298 154 629 262 142
Other special types 494 194 110 405 195 106
Mixed NST and other tumour types 750 332 156 721 320 160
Lymphovascular invasion
Negative 765  < 0.001 322 0.003 155 <0.001 758  < 0.001 329 0.6 155 <0.001
Positive 933 388 236 912 338 237
Lymph node status
Negative 767  < 0.001 323 0.06 157 0.1 763 0.009 326 0.2 155 0.04
Positive 866 357 177 837 345 189
Progesterone receptor
Negative 815 0.2 360 0.05 159 0.9 757 0.3 339 0.5 138 0.2
Positive 780 323 160 782 328 162
Ki67 index
Low ( < 20%) 301  < 0.001 140  < 0.001 NA NA 297  < 0.001 140  < 0.001 NA NA
High ( ≥ 20%) 414 183 409 182

NA not applicable.

Significant p-values are in bold (Mann-Whitney test).